Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -35.99-579.49-62.36150.21-353.26

What is the latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL is -35.99 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-35.99
Mar2023-579.49
Mar2022-62.36
Mar2021150.21
Mar2020-353.26

How is Core EBITDA Growth of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Growth % Change
Mar2024 -35.99
Negative
Mar2023 -579.49
Negative
Mar2022 -62.36
Negative
Mar2021 150.21
Positive
Mar2020 -353.26 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Growth ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹259.0 Cr -0% -8.7% 36.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,666.0 Cr -3.5% 0% -12.9% Stock Analytics
DIVIS LABORATORIES ₹151,060.0 Cr -6.6% -7.2% 9.8% Stock Analytics
CIPLA ₹121,080.0 Cr -2.8% -5% -7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,605.0 Cr -2.5% -0.4% 1.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,556.0 Cr -3.8% -0.6% -4.2% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-0%

-8.7%

36.2%

SENSEX

-2.7%

-0.5%

-5.3%


You may also like the below Video Courses